CD8A and malignant colon neoplasm: Furthermore, we identified these CD8+ T-cells as the major instigators of the strong prophylactic and therapeutic antitumor effects observed in mice challenged with mp53 and expressing murine colon cancer MC38 tumor cells (Fig. 3, 4, and 5).